Not provided
Not provided
Not provided
Not provided
Not provided
Unable to enroll. Change in patient population.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This research study is being done in order to find out if there is any difference in the effectiveness of ultrasound guided supraclavicular brachial plexus nerve block that can be achieved with 3 different amounts of ropivacaine 0.5% (20 ml, 30 ml, and 40 ml). The investigators want to show if you can have a successful nerve block with less amount of local anesthetic, thus potentially decreasing the risk of side effects.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group R20 | Active Comparator | Patient will receive 20 ml of ropivacaine 0.5% for their ultrasound guided supraclavicular block. |
|
| Group R30 | Active Comparator | Patient will receive 30 ml of ropivacaine 0.5% for their ultrasound guided supraclavicular block. |
|
| Group R40 | Active Comparator | Patient will receive 40 ml of ropivacaine 0.5% for their ultrasound guided supraclavicular block. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| 20 ml of ropivacaine 0.5% | Drug | Patient will receive 20 ml of ropivacaine 0.5% for their ultrasound guided supraclavicular block. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Onset of analgesia | First 30 minutes | |
| Duration of analgesia | 24 hours |
| Measure | Description | Time Frame |
|---|---|---|
| Total analgesic use | First 24 hours |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jaime Ortiz, MD | Baylor College of Medicine | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ben Taub General Hospital | Houston | Texas | 77030 | United States |
Not provided
| ID | Term |
|---|---|
| D000377 | Agnosia |
| D010146 | Pain |
| ID | Term |
|---|---|
| D010468 | Perceptual Disorders |
| D019954 | Neurobehavioral Manifestations |
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 30 ml of ropivacaine 0.5% | Drug | Patient will receive 30 ml of ropivacaine 0.5% for their ultrasound guided supraclavicular block. |
|
| 40 ml of ropivacaine 0.5% | Drug | Patient will receive 40 ml of ropivacaine 0.5% for their ultrasound guided supraclavicular block. |
|
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |